MedTrace Logo

What Are the Effects of Fibrinogen Concentrate Administration on Biological Parameters

NCT03944382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2020-02-28

No results posted yet for this study

Summary

the fibrinogen concentrate are given since 50 years with the dose of 2g for a afibrinogenemia. But this dose has been fixed 40 years ago and from now nobody discuss this quantity. Through this retrospective study the investigators tried to explore the evolution of blood test after a prescription of fibrinogen concentrate

Conditions

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Olivier DURANTEAU, Trainee · Erasme UH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03944382 on ClinicalTrials.gov